Researchers identify variation in gene PLD3 can increase risk of late-onset Alzheimer’s disease

Share via AddThis
Posted December 27, 2013

A new study, part-funded by the Medical Research Council (MRC), the Wellcome Trust and Alzheimer’s Research UK, has shown that a fault in a gene called phospholipase D3 (PLD3) can contribute to the overproduction of amyloid-beta in the brain. Increased levels of this chemical are associated with an increased chance of developing Alzheimer’s disease and the results show that, in certain cases, this can double an individual’s risk.

An international team of researchers in the UK and the US have been using genome-wide association studies (GWAS) to identify common genetic traits in the population that can influence a person’s risk of contracting Alzheimer’s disease after the age of 60 (known as Late Onset Alzheimer’s Disease or LOAD). They then cross-analysed the data from the GWAS studies using a process known as whole-exome sequencing on 14 families with four or more members affected by Alzheimer’s. Focussing on families heavily affected by the disease, the team used a new process to identify less common genes that could have the most severe effect.

By improving researchers’ understanding of how this gene’s activity is linked to amyloid-beta production and Alzheimer’s disease, this study will open up new avenues of research for drug development and could potentially help identify people who are more vulnerable to the disease.

Read more at: MedicalXpress



54,099 science & technology articles

Categories

Our Articles (see all)

General News

Follow us

Facebook   Twitter   Pinterest   StumbleUpon   Plurk
Google+   Tumblr   Delicious   RSS   Newsletter via Email

Featured Video (see all)


Using static electricity, insect-sized flying robots can land and stick to surfaces
Small drones need to stay aloft do their jobs — whether that’s searching for dangerous gas leaks or…

Featured Image (see all)

NASA’s rodent habitat, developed at Ames Research Center in Moffett Field, California, serves as a home away from home for mice on the International Space Station. Previous rodent experiments aboard space shuttles contributed to the development of new drugs now fighting osteoporosis on Earth.

Credits: NASA
Mice Studies in Space Offer Clues on Bone Loss
Astronauts know their bodies will be tested during time spent on the International Space Station, from the 15…